cancer sequencing
Realm IDx Cancer Genome Profiling Test Gets National Health Coverage in Japan
The company said it will launch the test, which combines DNA and RNA analysis, for research use only in markets outside of Japan.
Illumina, Pillar Biosciences Ink Global Distribution Agreement for Cancer Dx Assays
The firms said their distribution deal will facilitate the integration of Pillar's precision oncology assays and Illumina's sequencers.
Japanese Lung Cancer Genomic Screening Project Expands in Asia-Pacific
LC-SCRUM-Asia, a genomic screening project and database that initially launched in Japan in 2013, is expanding and will cover additional countries in the Asia-Pacific region.
Thermo Fisher Introduces Homologous Recombination Deficiency Score for Cancer Profiling Assay
Premium
The firm is also bringing its comprehensive genomic profiling assay for cancer to the Ion Torrent Genexus sequencing platform in the first half of 2023.
MDIC Launches Initiative to Improve Accuracy of Next-Generation Sequencing-Based Cancer Diagnostics
As part of the initiative, MDIC will manufacture, validate, and distribute reference samples to support the validation of NGS-based cancer diagnostics.
Feb 25, 2021
Natera Revenues Grow 35 Percent in Q4
Feb 25, 2021
NantHealth Q4 Revenues Flat From Year Ago
Nov 5, 2020
NantHealth Q3 Revenues Tick Up Slightly
Sep 11, 2020